Finally, to validate the in vitro cell line and in vivo mouse data, we performed a clinical survey of IHC staining on 72 human RCC samples using antibodies against AR or CD31, the key EC marker during the development of blood vessels that supply nutrition during tumor progression and metastasis29. Here, PECAM1 is linked to renal cell carcinoma.